RAD-x Management GmbH

Based in Germany, RAD-x Management GmbH provides diagnostic imaging solutions, focusing on radiology and nuclear medicine to enhance patient care through advanced medical technologies. RAD-x Management GmbH specializes in diagnostic imaging, headquartered in Mannheim, Germany. Founded in 2016 by Arthur Vogt, the company has engaged in one recorded deal, which occurred on September 1, 2016, when Gilde Healthcare Partners acquired RAD-x SAS. Martin Hardens and Roshen Thomas currently serve as the CEO.

RAD-x operates as a pan-European diagnostic imaging operator, offering high-quality medical care through radiology and nuclear medicine services. The company provides comprehensive imaging solutions that support accurate diagnosis and treatment across various medical conditions. With a client base including hospitals, private practices, and healthcare institutions primarily in Germany, Switzerland, and Austria, RAD-x focuses on integrating advanced technologies to improve patient care and operational efficiencies. In 2021, RAD-x reported a revenue of EUR 31,678,766.

60, with an EBITDA of EUR -6,751,350. 20. The company generates revenue through strategic partnerships with medical practices and healthcare providers, focusing on long-term collaborations that enhance efficiency and services for patients. RAD-x plans to expand its operations and services in the diagnostic imaging sector through the development of new products and the potential entry into new markets across Europe.

Recent funding from Gilde Healthcare Partners will support these initiatives, although specific product launch dates and geographic targets are not detailed. The last known deal took place in September 2016, indicating a strategic alignment for future growth.